SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy
Clinical trial NCT05233163 · COMPLETED
Trial details
- NCT number
- NCT05233163
- Sponsor
- Columbia University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2023-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.